Observations from this cohort indicate that in pediatric patients receiving BU-CY regimen prior to allogeneic HSCT age, viral infection status, CYP2C9 and GSTM1 genotype status are important predictors of HC occurrence. Here, CYP2C9 is linked to viral infectious disease.